SecBot SecBot
8-K ·Filed May 1, 2026

HAE

HAEMONETICS CORP
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0000313143-26-000023
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No immediate trading implications. Monitor for any future board composition changes or strategic shifts, but this individual departure is routine.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$55.32
T+0 close · May 1, 2026 · via day close
Latest settled
+54.41%
T+60 · $85.42
Vs SPY
+52.55%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 4 $55.32entry
  2. T+1 · 7mo ago +0.54%α −0.25% · $55.62
  3. T+5 · 6mo ago −5.57%α −8.50% · $52.24
  4. T+20 · 6mo ago +21.51%α +15.87% · $67.22
  5. T+60 · 4mo ago +54.41%α +52.55% · $85.42

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Charles J. Dockendorff will not stand for re-election at Haemonetics' 2026 annual meeting, continuing to serve until then. His departure is not due to any disagreement with the company, making this a routine board transition with no expected impact on operations or strategy.

Key Facts

  • Charles J. Dockendorff informed the company on April 27, 2026 that he will not stand for re-election at the 2026 annual meeting.
  • Dockendorff has served as a director since 2014 and remains a member of the Audit and Governance/Compliance Committees until the meeting.
  • The decision is explicitly stated as not resulting from any disagreement with Haemonetics.

Financial Impact

No financial impact; routine director departure.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000313143-26-000023
Document: 0000313143-26-000023-index-headers.html0000313143-26-000023
Document: 0000313143-26-000023-index.html0000313143-26-000023
Document: 0000313143-26-000023.txt0000313143-26-000023

Track record

14 reports on HAE

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +2.44% at T+5 after the Oct 20, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $122.71 Now $121.34 −1.12% settles Nov 19
  2. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  3. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $124.11 to $122.71 Now $121.34 −2.23% ▼ −1.13% −4.42% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $117.11 to $119.97 Now $121.34 +3.61% ▲ +2.44% +2.89% vs SPY
  5. Oct 19, 202628d ago Press Release Bullish 7/10 Entry $118.21 to $119.97 Now $121.34 +2.65% ▲ +1.49% +1.41% vs SPY
  6. Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $122.06 to $118.73 Now $121.34 −0.59% ▼ −2.73% −1.23% vs SPY
  7. Oct 8, 20265w ago 8-K Neutral 4/10 Entry $119.47 to $121.29 Now $121.34 +1.57% ▲ +1.52% +1.80% vs SPY
  8. Sep 30, 20266w ago Press Release Neutral 1/10 Entry $104.37 to $119.47 Now $121.34 +16.26% ▲ +14.47% +13.17% vs SPY
  9. Sep 30, 20266w ago Court Ruling Neutral 3/10 Entry $104.37 to $119.47 Now $121.34 +16.26% ▲ +14.47% +13.17% vs SPY
  10. Aug 18, 202612w ago 8-K Neutral 3/10 Entry $104.65 to $108.32 Now $121.34 +15.95% ▲ +3.51% +3.71% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens Wed (11h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026